Related Experiment Video

Updated: Jun 1, 2025

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases
05:02

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases

Published on: October 24, 2019

31.1K

Incidence, distribution, and patient characteristics of childhood cancer in Jordan: an updated population-based study

Ranya Baddourah1, Dana Baddourah1, Dalia Alsweedan1

  • 1Department of Pediatrics and Neonatology, Jordan University of Science and Technology, Irbid, Jordan.

Hematology/Oncology and Stem Cell Therapy
|January 20, 2025
PubMed

Insights

This study offers updated pediatric cancer epidemiology in Jordan from 2000-2017, revealing incidence rates and distribution patterns for clinicians and policymakers. The findings provide crucial data for understanding childhood cancer trends in the Middle East.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Public Health

Background:

  • Previous pediatric cancer epidemiology study in Jordan was published in 2003.
  • Need for updated data for clinicians, policymakers, and international researchers.

Purpose of the Study:

  • To provide updated epidemiological data on childhood malignancies in Jordan.
  • To inform local and international stakeholders about pediatric cancer in the region.

Main Methods:

  • Analysis of data from the Jordanian National Cancer Registry (2000-2017).
  • Inclusion of pediatric patients aged 0-18 years.
  • Classification using the International Classification of Childhood Cancer, third edition.

Main Results:

  • A cohort of 7639 pediatric cancer patients was analyzed.
  • Mean age at diagnosis was 8.68 years; male-to-female ratio was 1.4.
  • Identified significant differences in cancer distribution compared to neighboring Middle Eastern countries and regional variations.

Conclusions:

  • This study presents the most current organized data on childhood malignancies in Jordan.
  • The findings are essential for guiding clinical practice and health policy.
Abstract

More Related Videos

Detecting Anastasis In Vivo by CaspaseTracker Biosensor20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

9.2K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

209

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.0K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
83
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
338
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.7K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K